Financhill
Buy
57

AYI Quote, Financials, Valuation and Earnings

Last price:
$266.18
Seasonality move :
3.41%
Day range:
$261.81 - $267.76
52-week range:
$217.64 - $345.30
Dividend yield:
0.24%
P/E ratio:
19.45x
P/S ratio:
2.16x
P/B ratio:
3.32x
Volume:
250.8K
Avg. volume:
296.4K
1-year change:
0.59%
Market cap:
$8.2B
Revenue:
$3.8B
EPS (TTM):
$13.58

Earnings Data

Next earnings date for AYI
Apr 03
2025
Most recent earnings per share
$3.35
Missed by $0.55
(Jan 8/2025)
Consensus Estimate
$3.90
(Jan 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AYI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/31/2025 Q2 $1.2B -- -- $4.62 --
04/03/2025 Q1 $1B -- -- $3.74 --
01/08/2025 Q4 $955.6M $951.6M $3.35 $3.90 -$0.55
10/01/2024 Q3 $1B $1B $3.77 $4.27 -$0.50
06/27/2024 Q2 $996.5M $968.1M $3.62 $4.08 -$0.46
04/03/2024 Q1 $908M $905.9M $2.84 $3.23 -$0.39
01/09/2024 Q4 -- -- $3.21 $3.23 -$0.02
10/04/2023 Q3 -- -- $2.63 $3.73 -$1.10
06/29/2023 Q2 -- -- $3.28 $3.73 -$0.45
04/04/2023 Q1 -- -- $2.57 $2.73 -$0.16
01/09/2023 Q4 -- -- $2.29 $3.02 -$0.73
10/04/2022 Q3 -- -- $3.48 $3.61 -$0.13
06/30/2022 Q2 -- -- $3.07 $2.91 $0.16
04/05/2022 Q1 -- -- $2.13 $2.37 -$0.24
01/07/2022 Q4 -- -- $2.46 $2.41 $0.05
10/06/2021 Q3 -- -- $2.72 $2.87 -$0.15
07/01/2021 Q2 -- -- $2.37 $2.28 $0.09
03/31/2021 Q1 -- -- $1.74 $1.74 -$0.00
01/07/2021 Q4 -- -- $1.57 $1.86 -$0.29
10/08/2020 Q3 -- -- $1.87 $2.01 -$0.14
06/30/2020 Q2 -- -- $1.52 $1.35 $0.17
04/02/2020 Q1 -- -- $1.44 $1.90 -$0.46
01/09/2020 Q4 -- -- $1.44 $2.21 -$0.77
10/02/2019 Q3 -- -- $2.42 $2.82 -$0.40
07/02/2019 Q2 -- -- $2.22 $2.51 -$0.29
04/03/2019 Q1 -- -- $1.67 $1.78 -$0.11
01/09/2019 Q4 -- -- $1.98 $2.13 -$0.15
10/03/2018 Q3 -- -- $2.70 -- --
07/03/2018 Q2 -- -- $1.80 -- --
04/04/2018 Q1 -- -- $2.33 -- --
01/09/2018 Q4 -- -- $1.70 -- --
10/04/2017 Q3 -- -- $2.15 -- --
06/29/2017 Q2 -- -- $1.90 -- --
04/04/2017 Q1 -- -- $1.53 -- --
01/09/2017 Q4 -- -- $1.86 -- --
10/05/2016 Q3 -- -- $1.89 -- --
06/29/2016 Q2 -- -- $1.69 -- --
04/06/2016 Q1 -- -- $1.49 -- --
01/08/2016 Q4 -- -- $1.57 -- --
10/07/2015 Q3 -- -- $1.38 -- --
07/01/2015 Q2 -- -- $1.48 -- --

Acuity Brands Earnings Questions

  • How Much did Acuity Brands Generate in Revenue Last Quarter?

    Acuity Brands reported $951.6M worth of top line sales in its most recent quarter.

  • Did Acuity Brands Beat Earnings Last Quarter?

    Acuity Brands announced earnings per share of $3.35 which represents a miss of analyst forecast a $3.90 per share.

  • Is Acuity Brands Profitable?

    Acuity Brands reported $449.3M that represents $14.13 per share over the last quarter.

  • What is the Analyst Consensus for Acuity Brands EPS Next Year?

    Acuity Brands's earnings are forecast to grow from $13.44 per share to $15.52 per share next year representing an increase of 29.56%.

  • When is Acuity Brands's Earnings Date?

    Acuity Brands's next earnings date is April 3, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is up 0.57% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock